CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter
Oncolytic Virotherapy · 2016
DOI: 10.2147/ov.s112107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncolytic Virotherapy, 2016. Verfasst von Shilpa Bhatia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA.
- Departments of Pathology and Surgery, University of Alabama at Birmingham, Birmingham, AL.
- Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Bhatia, S., O'Bryan, S. M., Rivera, A. A., Curiel, D. T., & Mathis, J. M. (2016). CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter. Oncolytic Virotherapy. https://doi.org/10.2147/ov.s112107
Vancouver
Bhatia S, O'Bryan SM, Rivera AA, Curiel DT, Mathis JM. CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter. Oncolytic Virotherapy. 2016. doi:10.2147/ov.s112107
BibTeX
@article{Bhatia2016,
author = {Bhatia, Shilpa and O'Bryan, Samia M and Rivera, Angel A and Curiel, David T and Mathis, J Michael},
title = {CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter},
journal = {Oncolytic Virotherapy},
year = {2016},
doi = {10.2147/ov.s112107}
}
EUVIMED